Celyad SA (Belgium) Executives

CYAD Stock  EUR 0.67  0.02  3.08%   
Celyad SA employs about 95 people. The company is managed by 33 executives with a total tenure of roughly 167 years, averaging almost 5.0 years of service per executive, having 2.88 employees per reported executive. Discussion of Celyad SA's management performance can provide insight into the enterprise performance.
Filippo Petti  CEO
Chief Executive Officer, Chief Financial Officer, Director
Michel Lussier  Chairman
Chairman of the Board, Co-Founder
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celyad SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Celyad SA Management Team Effectiveness

The company has return on total asset (ROA) of (0.2933) % which means that it has lost $0.2933 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9264) %, meaning that it generated substantial loss on money invested by shareholders. Celyad SA's management efficiency ratios could be used to measure how well Celyad SA manages its routine affairs as well as how well it operates its assets and liabilities.

Celyad SA Workforce Comparison

Celyad SA is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 11,852. Celyad SA maintains roughly 95.0 in number of employees contributing less than 1% to equities under Health Care industry.

Celyad SA Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Celyad SA Price Series Summation is a cross summation of Celyad SA price series and its benchmark/peer.

Celyad SA Notable Stakeholders

A Celyad SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Celyad SA often face trade-offs trying to please all of them. Celyad SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Celyad SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Filippo PettiChief Executive Officer, Chief Financial Officer, DirectorProfile
Michel LussierChairman of the Board, Co-FounderProfile
Carri DuncanVice President Corporate Development and CommunicationsProfile
Richard MountfieldVice President of Global Regulatory AffairsProfile
Peter WaeleMember of the Executive Management Committee, Vice President - Research & DevelopmentProfile
Georges RawadiVice President - Business DevelopmentProfile
Anne MooreVice President Corporate StrategyProfile
Gaetane MetzChief Operating OfficerProfile
Jaak MintenDirector Clinical Affairs, representing Fakkel SPRLProfile
Roland GordonBeresfordRegulatory Affairs and IP DirectorProfile
William WijnsNon-Executive Director, permanent representative of the Cardiovascular Center Aalst CVBAProfile
Hanspeter SpekNon-Executive DirectorProfile
JeanMarc HeynderickxIndependent DirectorProfile
Serge GobletNon-Executive DirectorProfile
Louise ProulxIndependent DirectorProfile
Chris BuyseIndependent Director, permanent representative of Life Sciences Research PartnersProfile
Rudy DekeyserIndependent DirectorProfile
Margo RobertsDirectorProfile
Anne PortzenheimCommunication ManagerProfile
David GeorgesVP AdminProfile
MD MBChBChief OfficerProfile
Sara ZelkovicCommunications DirectorProfile
Stephen RubinoChief Business OfficerProfile
Hannes IserentantHead PropertyProfile
BME MBACFO, CoFounderProfile
Dominic PiscitelliIndependent DirectorProfile
Frdric LehmannVP AffairsProfile
Maria KoehlerIndependent DirectorProfile
Philippe NobelsChief HRProfile
An PhanHead LegalProfile
Philippe DechampsChief Legal OfficerProfile
Marina UdierBlagovicDirectorProfile
Seron AymericProgram ManagerProfile

About Celyad SA Management Performance

The success or failure of an entity such as Celyad SA often depends on how effective the management is. Celyad SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Celyad management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Celyad management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor-T cell-based therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. CELYAD ONCOLOGY operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 87 people.

Celyad SA Workforce Analysis

Traditionally, organizations such as Celyad SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Celyad SA within its industry.

Celyad SA Manpower Efficiency

Return on Celyad SA Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee279.1K
Net Loss Per Executive803.4K
Working Capital Per Employee1M
Working Capital Per Executive3M

Additional Tools for Celyad Stock Analysis

When running Celyad SA's price analysis, check to measure Celyad SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celyad SA is operating at the current time. Most of Celyad SA's value examination focuses on studying past and present price action to predict the probability of Celyad SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celyad SA's price. Additionally, you may evaluate how the addition of Celyad SA to your portfolios can decrease your overall portfolio volatility.